PLAC1 Antibodies

Santa Cruz Biotechnology provides a broad selection of PLAC1 monoclonal antibodies for investigating Placenta-specific 1 (PLAC1) protein function. PLAC1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PLAC1 is a crucial protein involved in placental development and plays significant roles in various reproductive processes. Expression of PLAC1 is primarily restricted to trophoblasts, making it an important marker for studies related to pregnancy and placental function. Recent research has revealed PLAC1's association with certain cancers, highlighting its potential as a target for therapeutic interventions. Understanding PLAC1's molecular mechanisms and signaling pathways can provide valuable insights into both normal development and disease progression. PLAC1 research continues to expand our knowledge of placental biology and reproductive health. Ongoing studies of PLAC1 may lead to breakthroughs in treating pregnancy complications and cancer therapies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PLAC1's role in human health and disease.